Gaps in the Iranian Patenting System: A Barrier to Nanomedicine CommercializationPayam Mansour Hosseini*, Seyed Reza Hejazi and Abolghasem Arabiun
Entrepreneurship faculty, University of Tehran, Tehran, Iran
- *Corresponding Author:
- Payam Mansour Hosseini
Entrepreneurship faculty, University of Tehran
P. O. Box 14395-796, Tehran, Iran
E-mail: [email protected]ac.ir
Received Date: May 30, 2012; Accepted Date: September 18, 2012; Published Date: September 21, 2012
Citation: Hosseini PM, Hejazi SR, Arabiun A (2012) Gaps in the Iranian Patenting System: A Barrier to Nanomedicine Commercialization. J Nanomed Biotherapeut Discov 2:108. doi:10.4172/2155-983X.1000108
Copyright: © 2012 Hosseini PM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Nanotechnology is developing rapidly in the world. Nanomedicine as one of the branches of nanotechnology
is very important. Getting patents in the field of nanomedicine is significant. The filing of patents plays a very
important role in nanomedicine commercialization. In this article, the procedures for getting a patent in Iran and the United States are described. The Turkish patent system has also been described. By comparing the procedures for getting a patent and interviews with experts, gaps in an Iranian patent are discussed. Finally, some reformation options for improving the procedures for getting an Iranian patent in nanomedicine, have been proposed.